Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |